chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Vaccination site pain
Clinical narrative: Chills; Headache; Fatigue; Soreness at injection site; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EW0175) via an unspecified route of administration in the right arm on 28Apr2021 at 12:30 PM (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medications the patient received within 2 weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EW0150) in the right arm on 02Apr2021 at 11:00 AM (at the age of 41-years-old) for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 29Apr2021 at 07:30, the patient experienced chills, headache, fatigue and soreness at injection site. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the events chills, headache, fatigue and soreness at injection site was recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Haematocrit, Haematocrit decreased, Haemoglobin, Haemoglobin decreased, Red blood cell count
Clinical narrative: RBC low; HCT low; HEM low; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 16:00 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 12Apr2021, the patient's red blood cells (RBC) were low, hematocrit (HCT) was low and hemoglobin (HEM) was low. The events resulted in the emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of events which included a treatment of hydration. The clinical outcome of the events RBC low, HCT low, and HEM low were recovered on an unknown date in Apr2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell count decreased
Clinical narrative: RBC low; HCT low; HEM low; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 16:00 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 12Apr2021, the patient's red blood cells (RBC) were low, hematocrit (HCT) was low and hemoglobin (HEM) was low. The events resulted in the emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of events which included a treatment of hydration. The clinical outcome of the events RBC low, HCT low, and HEM low were recovered on an unknown date in Apr2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Dry mouth, Headache, Nausea
Clinical narrative: Full body ache; Dry mouth; Dizziness; Drowsiness; Fever; Headache; Chills; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 25-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 29Apr2021 at 15:15 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 08Apr2021 at 15:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. On 30Apr2021 at 02:30, the patient experienced chills, fever, full-body ache, headache, drowsiness, dizziness, dry mouth, nausea which started approximately 12 hours from vaccine dose and lasting over 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, fever, full-body ache, headache, drowsiness, dizziness, dry mouth, nausea were unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Somnolence
Clinical narrative: Full body ache; Dry mouth; Dizziness; Drowsiness; Fever; Headache; Chills; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 25-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 29Apr2021 at 15:15 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 08Apr2021 at 15:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. On 30Apr2021 at 02:30, the patient experienced chills, fever, full-body ache, headache, drowsiness, dizziness, dry mouth, nausea which started approximately 12 hours from vaccine dose and lasting over 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, fever, full-body ache, headache, drowsiness, dizziness, dry mouth, nausea were unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Oropharyngeal pain, Pain, Pyrexia
Clinical narrative: Fever for two days; Body aches; Headache; Sore throat; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the right arm on 28Apr2021 at 16:15 (at the age of 17-year-old) as a single dose for COVID-19 immunisation. Medical history included migraine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 06:00, the patient experienced fever for two days, body aches, headache and sore throat. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever for two days was recovered on 30Apr2021 and of the body aches, headache and sore throat was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: Fatigue; Body ache; This is a spontaneous report from a non-contactable consumer, the patient. A 61-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in right arm on an unknown date in Mar2021 (at the age of 61-years old) as a single dose for COVID-19 immunisation. Medical history included hypothyroid. The patient had no known allergies to medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. On an unknown date in Mar2021, the patient experienced fatigue and body ache at 1 week. The patient had continued fatigue and body ache after 5 weeks. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fatigue and body ache were not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Migraine, Motion sickness, Nausea, Pain in extremity
Clinical narrative: Both of my hands were trembling within 12 hours of taking the vaccine. The next day both hands were still trembling, but then I noticed my legs were trembling. I couldnt keep them still. When Id prop them up or lie down, they were still trembling.; I also felt pain on the back side of my thigh, deep pain, nothing relieved it.; . I had a migraine the entire 3 days.; I had a fast and heavy heartbeat until I woke up the next day.; Injection site was expectedly painful for ~2 days; I had nausea on and off, like motion sickness, for the first 24 hours after inoculation.; I had nausea on and off, like motion sickness, for the first 24 hours after inoculation.; This is a spontaneous report from a non-contactable consumer, the patient. A 29-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0151) via an unspecified route of administration in the left arm on 09Apr2021 at 12:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The medical history included iron deficiency anemia, fibromyalgia, irritable bowel syndrome(IBS), possible endometriosis, allergy to latex and gluten. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included buspirone (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN), iron (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C) and vitamin d nos (MANUFACTURER UNKNOWN), all from unknown dates and for unknown indications. On 09Apr2021 at 23:00, within 12 hours of taking the vaccine, the patient experienced trembling on both of her hands, the next day both hands were trembling, but then she noticed her legs were trembling. The patient couldn't keep them still. When the patient prop them up or lie down, they were trembling. The patient also felt pain on the back side of her thigh, it was deep pain and nothing relieved it. This all lasted for 2-3 days and tapered off. The patient  had a migraine the entire three days and had a fast and heavy heartbeat until she woke up the next day. The patient's injection site was expectedly painful for approximately two days. The patient also had nausea on and off, like motion sickness, for the first 24 hours after inoculation. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event trembling on both hands and legs, pain on the back side of the thigh, migraine and injection site pain was recovered on an unknown date in Apr2021, while that of fast and heavy heartbeat, nausea and motion sickness was recovered on 10Apr2021.    No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor, Vaccination site pain
Clinical narrative: Both of my hands were trembling within 12 hours of taking the vaccine. The next day both hands were still trembling, but then I noticed my legs were trembling. I couldnt keep them still. When Id prop them up or lie down, they were still trembling.; I also felt pain on the back side of my thigh, deep pain, nothing relieved it.; . I had a migraine the entire 3 days.; I had a fast and heavy heartbeat until I woke up the next day.; Injection site was expectedly painful for ~2 days; I had nausea on and off, like motion sickness, for the first 24 hours after inoculation.; I had nausea on and off, like motion sickness, for the first 24 hours after inoculation.; This is a spontaneous report from a non-contactable consumer, the patient. A 29-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0151) via an unspecified route of administration in the left arm on 09Apr2021 at 12:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The medical history included iron deficiency anemia, fibromyalgia, irritable bowel syndrome(IBS), possible endometriosis, allergy to latex and gluten. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included buspirone (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN), iron (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C) and vitamin d nos (MANUFACTURER UNKNOWN), all from unknown dates and for unknown indications. On 09Apr2021 at 23:00, within 12 hours of taking the vaccine, the patient experienced trembling on both of her hands, the next day both hands were trembling, but then she noticed her legs were trembling. The patient couldn't keep them still. When the patient prop them up or lie down, they were trembling. The patient also felt pain on the back side of her thigh, it was deep pain and nothing relieved it. This all lasted for 2-3 days and tapered off. The patient  had a migraine the entire three days and had a fast and heavy heartbeat until she woke up the next day. The patient's injection site was expectedly painful for approximately two days. The patient also had nausea on and off, like motion sickness, for the first 24 hours after inoculation. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event trembling on both hands and legs, pain on the back side of the thigh, migraine and injection site pain was recovered on an unknown date in Apr2021, while that of fast and heavy heartbeat, nausea and motion sickness was recovered on 10Apr2021.    No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Paraesthesia, Pyrexia
Clinical narrative: Bodyache; Tingling; Chills; Fever; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 28Apr2021 at 10:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 07Apr2021 at 12:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. On 28Apr2021 at 23:00, the patient experienced chills, fever, headache, body ache and tingling. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of events chills, fever, headache, body ache and tingling were recovered on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Somnolence
Clinical narrative: Lots of sleep; Mild fatigue/ exhaustion; Headache; Causing joint pain; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Apr2021 at 08:45 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included ankylosing spondylitis. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included sulfasalazine (MANUFACTURER UNKNOWN) from an unknown date for unknown indication and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Mar2021 at 13:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 30Apr2021 at 12:00, 7 days after receiving second dose, the patient experienced mild fatigue, headache which continued through day 8, Symptoms increased on day 9 and 10 causing joint pain, exhaustion, and lots of sleep. The patient also reported that it seems odd to have side effects 1 week later. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of events mild fatigue, headache, joint pain, exhaustion and lots of sleep were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Nausea, Pyrexia
Clinical narrative: Chills; Low grade fever; Complete body muscle aches; Mild nausea; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 01May2021 at 15:15 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included fluticasone propionate (FLONASE), fexofenadine hydrochloride (ALLEGRA), xylitol; sodium chloride (XLEAR NASAL SPRAY) and ethinylestradiol; norgestimate (MILI) all from an unknown date for an unspecified indication. The patient previously took amoxicillin; clavulanic acid (AUGMENTIN) from an unknown date for an unspecified indication and experienced drug allergy. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 09Apr2021 at 13:15 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 02May2021 at 03:30, the patient experienced chills, low grade fever, complete body muscle aches, mild nausea, fatigue that lasted almost 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. Clinical outcome of the events chills, low grade fever, complete body muscle aches, mild nausea was recovered on an unspecified date in May2021. Whereas, the clinical outcome of the event fatigue recovered on 03May2021.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Body temperature, Chills, Fatigue, Headache
Clinical narrative: Headache; body aches; 102 temp; Chills; Sweating; food has no taste; tired/can't sleep; nauseous; tired/can't sleep; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0172) via an unspecified route of administration on the left arm on 30Apr2021 at 14:00(at the age of 57-year-old) as a single dose for COVID-19 immunisation. The medical history included basal cell skin cancer. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included varenicline tartrate (CHANTIX), rosuvastatin (ROSUVASTAT) and topiramate (MANUFACTURER UNKNOWN), all from unknown dates and for unknown indications. The patient previously took sulfur(MANUFACTURER UNKNOWN) and experienced allergy. On 30Apr2021 at 19:30, the patient experienced headache, body aches, 102 temp, chills, sweating, food had no taste, tired/can't sleep and nauseous. On 30Apr2021, the patient underwent body temperature test and the result was 102(unspecified units). The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, body aches, 102 temp, chills, sweating, food has no taste, tired/can't sleep and nauseous was recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Insomnia, Nausea, Pain
Clinical narrative: Headache; body aches; 102 temp; Chills; Sweating; food has no taste; tired/can't sleep; nauseous; tired/can't sleep; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0172) via an unspecified route of administration on the left arm on 30Apr2021 at 14:00(at the age of 57-year-old) as a single dose for COVID-19 immunisation. The medical history included basal cell skin cancer. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included varenicline tartrate (CHANTIX), rosuvastatin (ROSUVASTAT) and topiramate (MANUFACTURER UNKNOWN), all from unknown dates and for unknown indications. The patient previously took sulfur(MANUFACTURER UNKNOWN) and experienced allergy. On 30Apr2021 at 19:30, the patient experienced headache, body aches, 102 temp, chills, sweating, food had no taste, tired/can't sleep and nauseous. On 30Apr2021, the patient underwent body temperature test and the result was 102(unspecified units). The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, body aches, 102 temp, chills, sweating, food has no taste, tired/can't sleep and nauseous was recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea
Clinical narrative: Nausea 18 hours after; Fatigue and headache within an hour of vaccine; Fatigue and headache within an hour of vaccine; This is a spontaneous report from a contactable healthcare professional, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02May2021 at 13:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and anxiety. The patient had known allergy (unspecified). It was not reported if the patient received any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced fatigue and headache within an hour of vaccine on 02May2021. The patient experienced nausea 18 hours after on 03May2021 at 07:00. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events fatigue and headache within an hour of vaccine and nausea 18 hours after was resolving at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Lymphadenopathy, Pain
Clinical narrative: Sore arm.; Body aches; Joint pains; Swollen lymph nodes in arm pit; Tired.; Mild headache; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 at 15:15 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient received unspecified birth control medication within two weeks of vaccination.  The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Previously, the patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 15:15 (at the age of 31-year-old) as a single dose for COVID-19 immunisation.  On 29Apr2021 at 15:15, the patient experienced sore arm, body ache, joint pains, swollen lymph nodes in armpit, tired and mild headache. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events sore arm, body ache, joint pains, swollen lymph nodes in armpit, tired and mild headache were recovered on an unknown date in 2021.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm.; Body aches; Joint pains; Swollen lymph nodes in arm pit; Tired.; Mild headache; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 at 15:15 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient received unspecified birth control medication within two weeks of vaccination.  The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Previously, the patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 15:15 (at the age of 31-year-old) as a single dose for COVID-19 immunisation.  On 29Apr2021 at 15:15, the patient experienced sore arm, body ache, joint pains, swollen lymph nodes in armpit, tired and mild headache. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events sore arm, body ache, joint pains, swollen lymph nodes in armpit, tired and mild headache were recovered on an unknown date in 2021.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Body temperature, Chills, Fatigue, Headache
Clinical narrative: 100.2 temperature; minor chills; stomach ache; mild headache; exhaustion/fatigue; exhaustion/fatigue; At 3 hours-sore arm only; This is a spontaneous report from a non-contactable consumer, the patient. A  52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 01May2021 at 10:30 as a single dose for COVID-19 immunisation. The medical history included asthma, multiple allergies, high blood pressure, high cholesterol, allergy to dust, pet, smoke and seasonal allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included daily vitamin (unspecified), ezetimibe (ZETIA), atorvastatin (MANUFACTURER UNKNOWN)  and hydrochlorothiazide (MANUFACTURER UNKNOWN), all from unknown dates and for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 10Apr2021 at 10:00 as a single dose for COVID-19 immunisation. The patient also took previously codeine (MANUFACTURER UNKNOWN) and experienced allergy. On 01May2021 at 13:30, at 3 hours, the patient experienced sore arm. On 02May2021 at 10:30, at 24 hours, the patient experienced 100.2 temperature, minor chills, stomach ache, mild headache exhaustion and fatigue. On 02May2021, the patient underwent body temperature test and tested with a temperature of 100.2 (unspecified unit). The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the event 100.2 temperature, minor chills, stomach ache, mild headache, exhaustion and fatigue was recovered on an unknown date in May2021, while that of sore arm was resolving at the time of this report.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: 100.2 temperature; minor chills; stomach ache; mild headache; exhaustion/fatigue; exhaustion/fatigue; At 3 hours-sore arm only; This is a spontaneous report from a non-contactable consumer, the patient. A  52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 01May2021 at 10:30 as a single dose for COVID-19 immunisation. The medical history included asthma, multiple allergies, high blood pressure, high cholesterol, allergy to dust, pet, smoke and seasonal allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included daily vitamin (unspecified), ezetimibe (ZETIA), atorvastatin (MANUFACTURER UNKNOWN)  and hydrochlorothiazide (MANUFACTURER UNKNOWN), all from unknown dates and for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 10Apr2021 at 10:00 as a single dose for COVID-19 immunisation. The patient also took previously codeine (MANUFACTURER UNKNOWN) and experienced allergy. On 01May2021 at 13:30, at 3 hours, the patient experienced sore arm. On 02May2021 at 10:30, at 24 hours, the patient experienced 100.2 temperature, minor chills, stomach ache, mild headache exhaustion and fatigue. On 02May2021, the patient underwent body temperature test and tested with a temperature of 100.2 (unspecified unit). The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the event 100.2 temperature, minor chills, stomach ache, mild headache, exhaustion and fatigue was recovered on an unknown date in May2021, while that of sore arm was resolving at the time of this report.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Pityriasis rosea, Rash
Clinical narrative: Pityriasis rosea; Small patches of rash trailing from my neck down my abdomen.; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in right arm on 08Apr2021 at 14:30 (at the age of 21-years old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 10Apr2021, the patient had experienced and she small ovular blemish on the inside of the right arm, just under the elbow crease. The patient thought it was a burn but she was diagnosed at a clinic with pityriasis rosea, the mark on her arm being the herald and she have small patches of rash trailing from her neck down the abdomen. The events resulted in a visit to the doctors or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of adverse event, which included calamine lotion and allergy medication. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, pityriasis rosea and small patches of rash trailing from her neck down the abdomen was not recovered at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Lymphadenopathy, SARS-CoV-2 test
Clinical narrative: Swollen lymph nodes; cold chills; headaches; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 28Apr2021 at 18:00 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not provided. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0150) in the left arm on 03Apr2021 at 16:00 (at the age of 33-years-old) as a single dose for Covid-19 immunisation.  On 30Apr2021 the patient experienced swollen lymph nodes, cold chills and headaches. Therapeutic measures were not taken as a result of reported events.  Since the vaccination, the patient had been tested for COVID-19. On unknown date in 2021, patient underwent lab test and procedure which included Nasal swab COVID-19 test and the result was negative. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swollen lymph nodes, cold chills and headaches. was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Headache, Myalgia, Pain in extremity
Clinical narrative: Sore arm into armpit; Rash on chest; Sleepiness; Muscle ache; Joint aches; Sore arm; Headache; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: CW0173) via an unspecified route of administration in the left arm on 30Apr2021 at 09:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergy, depression and anaemia. The patient had known allergies to latex and melon. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN), armodafinil (MANUFACTURER UNKNOWN) and fluticasone (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 02Apr2021 at 09:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 12:00, the patient experienced sleepiness, muscle ache, joint aches, sore arm and headache. On 01May2021, the patient experienced the same events. On 02May2021, the patient experienced sleepiness, sore arm into armpit and rash on chest. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sleepiness, muscle ache, joint aches, sore arm, headache, sore arm into armpit and rash on chest was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Somnolence
Clinical narrative: Sore arm into armpit; Rash on chest; Sleepiness; Muscle ache; Joint aches; Sore arm; Headache; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: CW0173) via an unspecified route of administration in the left arm on 30Apr2021 at 09:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergy, depression and anaemia. The patient had known allergies to latex and melon. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN), armodafinil (MANUFACTURER UNKNOWN) and fluticasone (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 02Apr2021 at 09:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 12:00, the patient experienced sleepiness, muscle ache, joint aches, sore arm and headache. On 01May2021, the patient experienced the same events. On 02May2021, the patient experienced sleepiness, sore arm into armpit and rash on chest. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sleepiness, muscle ache, joint aches, sore arm, headache, sore arm into armpit and rash on chest was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Heavy menstrual bleeding, Intermenstrual bleeding
Clinical narrative: Worst cramps; Lots of spotting; Period was much heavier and more painful than usual; Period was much heavier and more painful than usual; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 17Apr2021 at 13:45 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 27Mar2021 at 15:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. The patient previously received cefaclor (MANUFACTURER UNKNOWN) for an unspecified indication on an unknown date and experienced drug allergy. On 21Apr2021, the patient had period on time but it was much heavier and more painful than usual. A few days after it ended, on 01May2021, the patient woke up in the middle of the night with the worst cramps she had in her entire life with lots of spotting and cramps were worse than when she had on full period. Her cycle was very regular so this was incredibly unusual and concerning. At the time of the reporting she was still in a lot of pain 3 days after. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as the result of events. The clinical outcome of the events period was much heavier and more painful than usual was recovered on an unknown date in Apr2021; while that of worst cramps and lots of spotting were recovering at the time of the report.  No follow-up attempts are possible. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pyrexia, Vomiting
Clinical narrative: Vomiting; normal symptoms of body aches; Fever; Arm pain; This is a spontaneous report from a non-contactable consumer, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 02May2021 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on an unknown date, as a single dose for COVID-19 immunisation. Concomitant medication included womens multivitamin (MANUFACTURER UNKNOWN) from an unknown date for unspecified indication and unknown if ongoing. On 03May2021 at 09:15, the patient experienced vomiting along with normal symptoms of body aches, fever, and arm pain. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events vomiting, body aches, fever, and arm pain were not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.